Bridgeway Capital Management’s Chembio diagnostics, Inc. CEMI Stock Holding History

Bridgeway Capital Management’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-13,900	Closed	-$146K	–	1544
2018 Q3	$146K	Hold	13,900	–	–	﹤0.01%	1355
2018 Q2	$154K	Sell	13,900 -10,900	-44%	-$98.1K	﹤0.01%	1333
2018 Q1	$198K	Sell	24,800 -55,300	-69%	-$442K	﹤0.01%	1269
2017 Q4	$657K	Hold	80,100	–	–	0.01%	1003
2017 Q3	$497K	Sell	80,100 -18,200	-19%	-$112K	0.01%	1095
2017 Q2	$595K	Hold	98,300	–	–	0.01%	1033
2017 Q1	$521K	Sell	98,300 -9,200	-9%	-$53.6K	0.01%	1062
2016 Q4	$731K	Hold	107,500	–	–	0.01%	933
2016 Q3	$792K	Hold	107,500	–	–	0.01%	896
2016 Q2	$880K	Hold	107,500	–	–	0.01%	827
2016 Q1	$644K	Hold	107,500	–	–	0.01%	942
2015 Q4	$573K	Hold	107,500	–	–	0.01%	1004
2015 Q3	$434K	Hold	107,500	–	–	0.01%	1096
2015 Q2	$528K	Hold	107,500	–	–	0.01%	1058
2015 Q1	$426K	Hold	107,500	–	–	0.01%	1156
2014 Q4	$419K	Buy	+107,500	New	+$445K	0.01%	1127

Other funds holding CEMI

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Bridgeway Capital Management's CEMI Position: Q4 2018 in Review

Bridgeway Capital Management sold out of Chembio diagnostics, Inc. (CEMI) in Q4 2018, closing a stake of 13,900 shares — an estimated $146K sold.

Bridgeway Capital Management first reported a position in CEMI in Q4 2014 and held it in 16 quarters. The position peaked at $880K in Q2 2016. 42 funds tracked by Wall St. Rank hold CEMI as of Q4 2018.

Bridgeway Capital Management reported no remaining Chembio diagnostics, Inc. position as of Q4 2018 after selling out during the quarter.
Bridgeway Capital Management sold 13,900 Chembio diagnostics, Inc. shares in Q4 2018, an estimated $146K.
Bridgeway Capital Management first reported a position in Chembio diagnostics, Inc. in Q4 2014 and held it in 16 quarters.
Bridgeway Capital Management's Chembio diagnostics, Inc. position peaked at $880K in Q2 2016.
42 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q4 2018.

Based on Bridgeway Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.